SNA 135.12 Snap-On Inc $SNA Hit a 52 week high of 137.43

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
SNA 135.12 Snap-On Inc $SNA Hit a 52 week high of 137.43 Currently at 135.12 -0.48 -0.35% With a day low of 134.14 and a total volume of 898,400.

SNA Snap-On Inc Recent Headline News

Snap-on announces 20.5% higher dividend of USD0.53 per share for quarter
M2 - Fri Nov 07, 6:17AM CST
Snap-on Incorporated (NYSE:SNA) reported on Friday that its board of directors approved a quarterly common stock dividend of USD0.53 per share.
SNA: 135.12 (-0.48)

Snap-on Raises Dividend 20.5%
Business Wire - Thu Nov 06, 3:54PM CST
Snap-on Incorporated (NYSE: SNA) today announced that its Board of Directors has declared a quarterly common stock dividend of $0.53 per share payable December 10, 2014, to shareholders of record on November 24, 2014. This represents an increase of $0.09 per share, or 20.5%, over Snap-on's previous quarterly dividend of $0.44 per share.
SNA: 135.12 (-0.48)

Snap-on to Present at Baird Industrial Conference
Business Wire - Mon Nov 03, 11:09AM CST
Snap-on Incorporated (NYSE: SNA) will present at the Robert W. Baird & Co. 2014 Industrial Conference on Wednesday, November 12, 2014. The presentation is scheduled to begin at approximately 9:00 a.m. Eastern (8:00 a.m. Central).
SNA: 135.12 (-0.48)

Stanley Black & Decker Q3 Earnings Crush Views
at Investor's Business Daily - Wed Oct 22, 11:25AM CDT
Stanley Black & Decker crushed third-quarter earnings views and topped revenue expectations as growth in its consumer do-it-yourself segment surged in both North America and Europe. Third-quarter earnings per share increased 13% to $1.55 a share....
SWK: 95.01 (+0.61), SNA: 135.12 (-0.48)

Company News for October 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:10AM CDT
Companies in the News are: MAT,SNA,ADS,KMI
KMI: 38.75 (+0.22), SNA: 135.12 (-0.48), MAT: 31.67 (+0.18), ADS: 283.61 (-1.37)

Snap-On
at Investor's Business Daily - Thu Oct 16, 5:51PM CDT
Snap-On (SNA) earned $1.76 a share in Q3, rising 23% from a year earlier and beating analysts' views by 33 cents. Revenue rose 14% to $859.9 mil, also beating views. Shares rose 6% to 121.39 and Snap-On's stock is up 11% for the year.
SNA: 135.12 (-0.48)

Snap-on (SNA) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Oct 16, 5:10PM CDT
The following Snap-on (SNA) conference call took place on October 16, 2014, 10:00 AM ET. This is a transcript of that earnings call:
SNA: 135.12 (-0.48)

Snap-on Tops Earnings & Revenues on Strong Segment Show - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 10:10AM CDT
Snap-on Inc. (SNA) reported strong third-quarter 2014 results with healthy growth in net sales and earnings.
NDSN: 77.64 (+0.46), SNA: 135.12 (-0.48), B: 36.42 (-0.08), MIDD: 94.00 (+1.79)

Snap-On posts 3Q profit
Automated Insights - Thu Oct 16, 6:15AM CDT
KENOSHA, Wis. (AP) _ Snap-On Inc. (SNA) on Thursday reported earnings of $103.7 million, or $1.76 per share, in its third quarter.
SNA: 135.12 (-0.48)

Snap-on Announces Third Quarter 2014 Results
Business Wire - Thu Oct 16, 6:00AM CDT
Snap-on Incorporated (NYSE: SNA), a leading global innovator, manufacturer and marketer of tools, equipment, diagnostics, repair information and systems solutions for professional users performing critical tasks, today announced operating results for the third quarter of 2014.
SNA: 135.12 (-0.48)

Will Snap-on Inc. (SNA) Keep the Earnings Streak Alive? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 10:40AM CDT
Snap-on Inc. (SNA) is set to report third-quarter 2014 results on Oct 16 before the opening bell.
HCA: 65.75 (-3.22), CW: 69.66 (-0.12), SNA: 135.12 (-0.48), AAPL: 109.01 (+0.31)

Snap-on Incorporated to Webcast 2014 Third Quarter Results Conference Call
Business Wire - Thu Oct 02, 11:15AM CDT
Snap-on Incorporated (NYSE: SNA) will release 2014 third quarter results prior to the market open on Thursday, October 16, 2014. A conference call to discuss the results will be held at 10:00am ET on that day. The conference call, with accompanying slides, will be webcast live via the Internet.
SNA: 135.12 (-0.48)

Snap-On Has Returned 17.6% Since SmarTrend Recommendation (SNA)
Comtex SmarTrend(R) - Fri Sep 26, 9:17AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 8 months, Snap-On has returned 17.63% as of today's recent price of $120.78.
SNA: 135.12 (-0.48)

Snap-On Up 22.1% Since SmarTrend Uptrend Call (SNA)
Comtex SmarTrend(R) - Thu Sep 18, 4:43PM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 22.07% as of today's recent price of $125.33.
SNA: 135.12 (-0.48)

Snap-On Shares Up 21.8% Since SmarTrend's Buy Recommendation (SNA)
Comtex SmarTrend(R) - Thu Sep 11, 11:01AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 21.80% as of today's recent price of $125.05.
SNA: 135.12 (-0.48)

Fitch Affirms Snap-on Inc.'s IDR at 'A-'; Outlook Stable
Business Wire - Mon Sep 08, 3:16PM CDT
Fitch Ratings has affirmed the ratings for Snap-on Inc. (NYSE: SNA), including the company's Issuer Default Rating (IDR) at 'A-'. The Rating Outlook is Stable. A complete list of rating actions follows at the end of this release.
SNA: 135.12 (-0.48)

Snap-On Has Returned 23.5% Since SmarTrend Recommendation (SNA)
Comtex SmarTrend(R) - Thu Sep 04, 9:40AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 23.46% as of today's recent price of $126.76.
SNA: 135.12 (-0.48)

Global Automotive Diagnostic Scan Tools Market Report 2014-2018
M2 - Thu Sep 04, 3:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lx94wg/global_automotive) has announced the addition of the "Global Automotive Diagnostic Scan Tools Market 2014-2018" report to their offering. The Global Automotive Diagnostic Scan Tools market will grow at a CAGR of 5.2% over the period 2014-2018. The automotive diagnostic scan tools were then used to diagnose any fault in a vehicle by plugging the cable into the vehicle's diagnostic connector and running a full scan. The major advantage of diagnostic scan tools is that it is easy to identify the fault and rectify it more quickly. To calculate the market size, the report covers revenue generated from the sales of OEM and aftermarket automotive diagnostic scan tools. It also presents the vendor landscape and a corresponding detailed analysis of the leading four vendors in the market. In addition, the report discusses the major drivers that influence the growth of the Global Automotive Diagnostic Scan Tools market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The presence of high-end vehicle manufacturers in developing countries is one of the major trends in the market. The Global Automotive market is poised to experience consistent growth in developing countries, which are witnessing a high adoption of vehicles from the Mid Car and Small Car segments. Vehicles in these segments use advanced electronic devices that require workshops to have diagnostic scan tools as standard equipment. According to the report, increased usage of electronic devices in vehicles is one of the major factors driving the Global Automotive Diagnostic Scan Tools market. Electronic devices in vehicles improve drivability, enhance safety features, lower environmental pollution, and provide greater operational efficiency. Further, the report states that the increased complexity of automotive electronic architecture poses a challenge for market growth. Automotive manufacturers provide advanced electronic devices for brand differentiation. As the complexity of architecture in these electronic devices differs from model to model, diagnostic scan tool manufacturers try to provide a universal diagnostic tool. Key Vendors - Denso Corp. - Snap-On Inc. - SPX Corp. - Softing AG Other Prominent Vendors - Actia Group SA - Avl List GmbH - Dg Technologies - Dsa Daten- Und Systemtechnik GmbH - Etas GmbH - General Technologies Corp - Hickok Inc. For more information visit http://www.researchandmarkets.com/research/lx...automotive
SPW: 92.86 (-0.08), SNA: 135.12 (-0.48)

Snap-on to Present at RBC Capital Markets' 2014 Global Industrials Conference
Business Wire - Tue Sep 02, 3:55PM CDT
Snap-on Incorporated (NYSE: SNA) will present at the 2014 RBC Capital Markets' Global Industrials Conference at 1:20 PM Pacific Time on Tuesday, September 9, 2014.
SNA: 135.12 (-0.48)

20.7% Return Seen to Date on SmarTrend Snap-On Call (SNA)
Comtex SmarTrend(R) - Thu Aug 28, 9:14AM CDT
SmarTrend identified an Uptrend for Snap-On (NYSE:SNA) on February 6th, 2014 at $102.67. In approximately 7 months, Snap-On has returned 20.66% as of today's recent price of $123.88.
SNA: 135.12 (-0.48)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading